Volume 2019, Issue 1 6853135
Case Series
Open Access

An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections

Joseph Faraj

Corresponding Author

Joseph Faraj

Department of Vascular Surgery, Royal Perth Hospital, Perth, Western Australia, Australia rph.wa.gov.au

Search for more papers by this author
Rebekah L. W. Tan

Rebekah L. W. Tan

Department of Vascular Surgery, Hollywood Private Hospital, Western Australia, Australia hollywoodprivate.com

Search for more papers by this author
Bibombe P. Mwipatayi

Bibombe P. Mwipatayi

Department of Vascular Surgery, Royal Perth Hospital, Perth, Western Australia, Australia rph.wa.gov.au

Department of Vascular Surgery, Hollywood Private Hospital, Western Australia, Australia hollywoodprivate.com

School of Medicine, University of Western Australia, Perth, Western Australia, Australia uwa.edu.au

Perth Institute of Vascular Surgery, Perth, Western Australia, Australia pivar.org

Search for more papers by this author
First published: 08 April 2019
Citations: 1
Academic Editor: Nikolaos Papanas

Abstract

Infrarenal abdominal aortic dissections (IAAD) are exceedingly rare, accounting for 1-4% of all aortic dissections. The evidence is scarce on how to best manage IAAD when they become symptomatic. Two main interventional approaches exist, open surgery and the endovascular approach. Conventional stent-graft systems make it difficult to treat nonaneurysmal aortic disease due to limb competition in a narrow distal aorta. Thus, we present a novel use of the Endologix Anatomical Fixation 2 (AFX2) Abdominal Aortic Aneurysm (AAA) endograft system for the treatment of four patients with IAAD. We also highlight an individual case study that was treated with an alternative endovascular approach and the complications that followed. This was to highlight and compare our successful experience with Endologix AFX2 AAA endograft system. There were multiple benefits for choosing this stent-graft; however the main advantage is its suitability in the narrow distal aorta. Our aim was to highlight an alternative endovascular approach for the successful treatment of a rare, challenging, and potentially fatal pathology.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.